Kurt Lockwood is a registered patent attorney and member of the intellectual property law firm of Seager Tufte Wickhem. He is based in the firm’s Boston office.
Kurt has garnered a thorough understanding of the business aspects of intellectual property, as well as the industries and technologies represented by Seager’s clients, with a career spanning experiences in private practice and as in-house IP counsel.
As a partner with Seager Tufte Wickhem, Kurt’s practice focuses on patent matters, including clients across a range of industries and technologies. Kurt has a particular expertise in medical device and healthcare technologies, including representations of Fortune 100 and mid-sized private and public companies. Prior to joining Seager in 2022, Kurt worked in private practice with a Boston-area IP boutique firm.
Prior to his return to private practice in 2015, Kurt worked in-house for thirteen years with Boston Scientific Corporation (BSC). Kurt was Vice President and Chief Patent Counsel for several business groups at BSC. His in-house experience at the company included: leading an intellectual property legal team in support of the Endoscopy, Urology & Women’s Health and Interventional Oncology divisions, having combined global revenues of $1.8B; development and execution of strategies to grow and enforce divisional worldwide IP portfolios, as a member of the divisional project investment and management boards of BSC; oversight of all IP aspects of numerous acquisitions, investments and divestitures, with a combined value in excess of $4.6B; and management of offensive and defensive IP litigation and EU opposition proceedings.
Kurt began his legal career with the IP boutique firm, Cushman Darby & Cushman, in Washington, D.C., and then with the general practice firm, Testa, Hurwitz & Thibeault, in Boston.
Raised in Southbridge, Massachusetts, Kurt received his J.D. degree from the Vanderbilt University School of Law and his B.S. degree in Chemistry from Syracuse University.
Practice Areas
- Acquisitions | Diligence
- Licensing | Transactional Agreements
- IP Counseling
- IP Portfolio Analysis, Strategy and Management
- Patent Prosecution – Domestic and Foreign
- Offensive Infringement | Validity Evaluations
- Patent Landscaping Studies
- Freedom to Operate (FTO) Reviews
- Defensive Invalidity | Non-Infringement Analyses | Opinions
Industry Sectors / Specialties
- Medical Devices
- Diagnostic |Analytical Devices
- Surgical | Aesthetic Equipment
- IOT, AI, ML — MedTech Applications
- Biotechnology | Life Sciences
Education
- Vanderbilt University Law School, J.D. (1994)
- Syracuse University, B.S., magna cum laude, Chemistry (1988)
Bar Admissions
- Massachusetts (1994)
- District of Columbia (1994)
- Fed. Cir. Court of Appeals
- U.S. Patent and Trademark Office (1995)
Honors
- IAM Strategy 300 – The World’s Leading IP Strategists” (2016)
- LMG Life Sciences Award – Intellectual Property (2018)
Publications
- “Treatment Method Patents After Fed. Circ. Vanda Ruling,” Kurt Lockwood, Erin Martell, Law360 (2018)
- Interviewed and quoted, “High Court May Put Limits On Foreign Reach Of US Patents,” Law360 (June 2016)
- “High Court Likely To Look At Scope Of US Patent Law Abroad,” Kurt Lockwood, Jerry O’Neil, Law360 (May 2016)